Leerink Partners Score: 42
Firm Overview & Performance
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+24.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
57%
261 W / 198 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
82%
169 W / 38 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
19%
40 W / 167 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
10%
21 W / 186 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
57%
160 W / 119 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
58%
235 W / 173 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
51%
26 W / 25 L
Latest Price Targets
| Date | Stock | Signal | Analyst | Target | Start Price | Best Price (1Y) | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 07, 2026 |
Akebia Therapeutics Inc.
AKBA
|
BUY | - |
$1.00
Est. +5%
|
$0.95 | $0.96 |
$0.87
-8.5%
|
| Aug 07, 2026 |
Natera Inc
NTRA
|
BUY | - |
$330.00
Est. +24%
|
$265.38 | $324.33 |
$310.78
+17.1%
|
| Aug 07, 2026 |
Halozyme Therapeutics Inc.
HALO
|
BUY | - |
$110.00
Est. +28%
|
$85.76 | $104.79 |
$100.67
+17.4%
|
| Aug 06, 2026 |
Insulet Corporation
PODD
|
BUY | Mike Kratky |
$145.00
Est. +9%
|
$133.26 | $146.80 |
$146.44
+9.9%
|
| Aug 06, 2026 |
Exelixis Inc
EXEL
|
SELL | Andrew Berens |
$52.00
Est. +1%
|
$52.59 | $49.97 (Low) |
$50.61
+3.8%
|
| Aug 06, 2026 |
GoodRx Holdings Inc - Ordinary Shares - Class A
GDRX
|
BUY | - |
$5.00
Est. +34%
|
$3.73 | $3.89 |
$3.72
-0.3%
|
| Aug 04, 2026 |
Keros Therapeutics Inc
KROS
|
BUY | - |
$23.00
Est. +127%
|
$10.11 | $11.42 |
$10.66
+5.4%
|
| Aug 04, 2026 |
Replimune Group Inc
REPL
|
BUY | Daina Graybosch |
$17.00
Est. +43%
|
$11.91 | $15.69 |
$15.19
+27.5%
|
| Aug 03, 2026 |
Incyte Corp.
INCY
|
BUY | Andrew Berens |
$155.00
Est. +30%
|
$119.52 | $124.57 |
$120.52
+0.8%
|
| Aug 03, 2026 |
Lantheus Holdings Inc
LNTH
|
BUY | - |
$102.50
Est. +1%
|
$101.91 | $102.90 |
$100.94
-1.0%
|
| Jul 30, 2026 |
Humana Inc.
HUM
|
BUY | - |
$513.00
Est. +40%
|
$365.89 | $393.64 |
$384.97
+5.2%
|
| Jul 30, 2026 |
Boston Scientific Corp.
BSX
|
BUY | - |
$60.00
Est. +30%
|
$46.04 | $52.34 |
$51.69
+12.3%
|
| Jul 24, 2026 |
Argen X SE - ADR
ARGX
|
BUY | - |
$1,065.00
Est. +15%
|
$924.60 | $935.88 |
$856.94
-7.3%
|
| Jul 24, 2026 |
Edwards Lifesciences Corp
EW
|
BUY | Mike Kratky |
$101.00
Est. +20%
|
$83.82 | $93.91 |
$92.56
+10.4%
|
| Jul 23, 2026 |
Medpace Holdings Inc
MEDP
|
BUY | - |
$620.00
Est. +2%
|
$605.82 | $677.90 |
$581.95
-3.9%
|
| Jul 22, 2026 |
Progyny Inc
PGNY
|
BUY | Michael Cherny |
$38.00
Est. +18%
|
$32.24 | $32.67 |
$25.89
-19.7%
|
| Jul 22, 2026 |
Celldex Therapeutics Inc.
CLDX
|
BUY | - |
$70.00
Est. +96%
|
$35.66 | $45.14 |
$42.61
+19.5%
|
| Jul 20, 2026 |
Gilead Sciences, Inc.
GILD
|
SELL | Daina Graybosch |
$127.00
Est. +5%
|
$133.21 | $127.61 (Low) |
$138.14
-3.7%
|
| Jul 20, 2026 |
Shattuck Labs Inc
STTK
|
BUY | - |
$16.00
Est. +112%
|
$7.53 | $7.94 |
$7.32
-2.8%
|
| Jul 17, 2026 |
Illumina Inc
ILMN
|
BUY | Puneet Souda |
$210.00
Est. +12%
|
$186.89 | $207.00 |
$192.64
+3.1%
|
| Jul 17, 2026 |
10x Genomics Inc - Ordinary Shares - Class A
TXG
|
SELL | - |
$40.00
Est. +9%
|
$44.12 | $42.75 (Low) |
$58.15
-31.8%
|
| Jul 17, 2026 |
Intuitive Surgical Inc
ISRG
|
BUY | Mike Kratky |
$454.00
Est. +13%
|
$402.33 | $404.98 |
$401.27
-0.3%
|
| Jul 17, 2026 |
Elevance Health Inc
ELV
|
BUY | - |
$395.00
Est. +7%
|
$369.28 | $404.72 |
$398.22
+7.8%
|
| Jul 16, 2026 |
Twist Bioscience Corp
TWST
|
BUY | Puneet Souda |
$110.00
Est. +19%
|
$92.61 | $126.24 |
$125.16
+35.1%
|
| Jul 06, 2026 |
Avalo Therapeutics Inc
AVTX
|
BUY | - |
$38.00
Est. +92%
|
$19.80 | $20.65 |
$19.45
-1.8%
|
| Jul 02, 2026 |
Pyxis Oncology Inc
PYXS
|
BUY | Jeffrey La Rosa |
$7.00
Est. +146%
|
$2.85 | $4.00 |
$3.01
+5.6%
|
| Jun 25, 2026 |
Lilly(Eli) & Co
LLY
|
BUY | David Risinger |
$1,232.00
Est. +10%
|
$1,117.26 | $1,249.45 |
$1,209.85
+8.3%
|
| Jun 25, 2026 |
Bio-Techne Corp
TECH
|
BUY | Market Perform |
$73.00
Est. +3%
|
$70.55 | $72.40 |
$72.17
+2.3%
|
| Jun 24, 2026 |
Rapport Therapeutics Inc.
RAPP
|
BUY | - |
$52.00
Est. +34%
|
$38.88 | $49.50 |
$47.36
+21.8%
|
| Jun 22, 2026 |
Definium Therapeutics, Inc.
DFTX
|
BUY | Marc Goodman |
$52.00
Est. +37%
|
$37.91 | $49.70 |
$43.90
+15.8%
|
| Jun 22, 2026 |
Regenxbio Inc
RGNX
|
BUY | Mani Foroohar |
$18.00
Est. +103%
|
$8.88 | $15.85 |
$10.66
+20.0%
|
| Jun 22, 2026 |
Altimmune Inc
ALT
|
BUY | Thomas Smith |
$10.00
Est. +232%
|
$3.01 | $3.40 |
$2.88
-4.3%
|
| Jun 18, 2026 |
uniQure N.V.
QURE
|
BUY | Joseph Schwartz |
$70.00
Est. +45%
|
$48.16 | $50.47 |
$47.06
-2.3%
|
| Jun 17, 2026 |
Unitedhealth Group Inc
UNH
|
BUY | Whit Mayo |
$462.00
Est. +13%
|
$407.65 | $461.00 |
$399.06
-2.1%
|
| Jun 16, 2026 |
Edgewise Therapeutics Inc
EWTX
|
BUY | - |
$52.00
Est. +56%
|
$33.28 | $48.40 |
$43.18
+29.7%
|
| Jun 11, 2026 |
Procept BioRobotics Corp
PRCT
|
SELL | - |
$29.00
Est. +0%
|
$29.09 | $16.68 (Low) |
$21.95
+24.5%
|
| Jun 08, 2026 |
Tango Therapeutics Inc
TNGX
|
BUY | - |
$69.00
Est. +121%
|
$31.17 | $33.53 |
$25.65
-17.7%
|
| Jun 05, 2026 |
Stryker Corp.
SYK
|
BUY | Mike Kratky |
$407.00
Est. +35%
|
$301.21 | $352.46 |
$341.09
+13.2%
|
| Jun 04, 2026 |
Nanobiotix - ADR
NBTX
|
BUY | Jonathan Chang |
$46.00
Est. +31%
|
$35.20 | $42.92 |
$38.17
+8.4%
|
| Jun 04, 2026 |
Absci Corp
ABSI
|
BUY | - |
$12.00
Est. +102%
|
$5.94 | $12.00 |
$9.46
+59.3%
|
| Jun 03, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY | Andrew Berens |
$165.00
Est. +81%
|
$91.35 | $123.99 |
$123.96
+35.7%
|
| Jun 02, 2026 |
Hims & Hers Health Inc - Ordinary Shares - Class A
HIMS
|
SELL | Michael Cherny |
$25.00
Est. +10%
|
$27.64 | $24.24 (Low) |
$28.77
-4.1%
|
| Jun 02, 2026 |
X4 Pharmaceuticals Inc
XFOR
|
BUY | Thomas Smith |
$12.00
Est. +192%
|
$4.11 | $4.82 |
$4.29
+4.4%
|
| Jun 02, 2026 |
Celcuity Inc
CELC
|
BUY | Andrew Berens |
$155.00
Est. +66%
|
$93.37 | $117.21 |
$86.60
-7.3%
|
| Jun 02, 2026 |
Fulcrum Therapeutics Inc
FULC
|
SELL | - |
$4.00
Est. +38%
|
$6.42 | $2.83 (Low) |
$3.71
+42.2%
|
| May 28, 2026 |
Icon Plc
ICLR
|
BUY | - |
$145.00
Est. +5%
|
$138.71 | $186.64 |
$167.48
+20.7%
|
| May 28, 2026 |
Boston Scientific Corp.
BSX
|
BUY | Mike Kratky |
$74.00
Est. +47%
|
$50.46 | $52.34 |
$51.69
+2.4%
|
| May 28, 2026 |
Equillium Inc
EQ
|
BUY | Thomas Smith |
$6.00
Est. +128%
|
$2.63 | $3.54 |
$2.01
-23.6%
|
| May 26, 2026 |
Lilly(Eli) & Co
LLY
|
BUY | David Risinger |
$1,119.00
Est. +5%
|
$1,065.00 | $1,249.45 |
$1,209.85
+13.6%
|
| May 22, 2026 |
Twist Bioscience Corp
TWST
|
BUY | Puneet Souda |
$80.00
Est. +36%
|
$58.84 | $126.24 |
$125.16
+112.7%
|
Akebia Therapeutics Inc.
AKBA
Aug 07, 2026
Analyst
-
Signal & Target
BUY
$1.00
Start Price
$0.95
Best Price (1Y)
$0.96
Current Price
$0.87
Return
-8.5%
Natera Inc
NTRA
Aug 07, 2026
Analyst
-
Signal & Target
BUY
$330.00
Start Price
$265.38
Best Price (1Y)
$324.33
Current Price
$310.78
Return
+17.1%
Halozyme Therapeutics Inc.
HALO
Aug 07, 2026
Analyst
-
Signal & Target
BUY
$110.00
Start Price
$85.76
Best Price (1Y)
$104.79
Current Price
$100.67
Return
+17.4%
Insulet Corporation
PODD
Aug 06, 2026
Analyst
Mike Kratky
Signal & Target
BUY
$145.00
Start Price
$133.26
Best Price (1Y)
$146.80
Current Price
$146.44
Return
+9.9%
Exelixis Inc
EXEL
Aug 06, 2026
Analyst
Andrew Berens
Signal & Target
SELL
$52.00
Start Price
$52.59
Best Price (1Y)
$49.97
Current Price
$50.61
Return
+3.8%
GoodRx Holdings Inc - Ordinary Shares - Class A
GDRX
Aug 06, 2026
Analyst
-
Signal & Target
BUY
$5.00
Start Price
$3.73
Best Price (1Y)
$3.89
Current Price
$3.72
Return
-0.3%
Keros Therapeutics Inc
KROS
Aug 04, 2026
Analyst
-
Signal & Target
BUY
$23.00
Start Price
$10.11
Best Price (1Y)
$11.42
Current Price
$10.66
Return
+5.4%
Replimune Group Inc
REPL
Aug 04, 2026
Analyst
Daina Graybosch
Signal & Target
BUY
$17.00
Start Price
$11.91
Best Price (1Y)
$15.69
Current Price
$15.19
Return
+27.5%
Incyte Corp.
INCY
Aug 03, 2026
Analyst
Andrew Berens
Signal & Target
BUY
$155.00
Start Price
$119.52
Best Price (1Y)
$124.57
Current Price
$120.52
Return
+0.8%
Lantheus Holdings Inc
LNTH
Aug 03, 2026
Analyst
-
Signal & Target
BUY
$102.50
Start Price
$101.91
Best Price (1Y)
$102.90
Current Price
$100.94
Return
-1.0%
Humana Inc.
HUM
Jul 30, 2026
Analyst
-
Signal & Target
BUY
$513.00
Start Price
$365.89
Best Price (1Y)
$393.64
Current Price
$384.97
Return
+5.2%
Boston Scientific Corp.
BSX
Jul 30, 2026
Analyst
-
Signal & Target
BUY
$60.00
Start Price
$46.04
Best Price (1Y)
$52.34
Current Price
$51.69
Return
+12.3%
Argen X SE - ADR
ARGX
Jul 24, 2026
Analyst
-
Signal & Target
BUY
$1,065.00
Start Price
$924.60
Best Price (1Y)
$935.88
Current Price
$856.94
Return
-7.3%
Edwards Lifesciences Corp
EW
Jul 24, 2026
Analyst
Mike Kratky
Signal & Target
BUY
$101.00
Start Price
$83.82
Best Price (1Y)
$93.91
Current Price
$92.56
Return
+10.4%
Medpace Holdings Inc
MEDP
Jul 23, 2026
Analyst
-
Signal & Target
BUY
$620.00
Start Price
$605.82
Best Price (1Y)
$677.90
Current Price
$581.95
Return
-3.9%
Progyny Inc
PGNY
Jul 22, 2026
Analyst
Michael Cherny
Signal & Target
BUY
$38.00
Start Price
$32.24
Best Price (1Y)
$32.67
Current Price
$25.89
Return
-19.7%
Celldex Therapeutics Inc.
CLDX
Jul 22, 2026
Analyst
-
Signal & Target
BUY
$70.00
Start Price
$35.66
Best Price (1Y)
$45.14
Current Price
$42.61
Return
+19.5%
Gilead Sciences, Inc.
GILD
Jul 20, 2026
Analyst
Daina Graybosch
Signal & Target
SELL
$127.00
Start Price
$133.21
Best Price (1Y)
$127.61
Current Price
$138.14
Return
-3.7%
Shattuck Labs Inc
STTK
Jul 20, 2026
Analyst
-
Signal & Target
BUY
$16.00
Start Price
$7.53
Best Price (1Y)
$7.94
Current Price
$7.32
Return
-2.8%
Illumina Inc
ILMN
Jul 17, 2026
Analyst
Puneet Souda
Signal & Target
BUY
$210.00
Start Price
$186.89
Best Price (1Y)
$207.00
Current Price
$192.64
Return
+3.1%
10x Genomics Inc - Ordinary Shares - Class A
TXG
Jul 17, 2026
Analyst
-
Signal & Target
SELL
$40.00
Start Price
$44.12
Best Price (1Y)
$42.75
Current Price
$58.15
Return
-31.8%
Intuitive Surgical Inc
ISRG
Jul 17, 2026
Analyst
Mike Kratky
Signal & Target
BUY
$454.00
Start Price
$402.33
Best Price (1Y)
$404.98
Current Price
$401.27
Return
-0.3%
Elevance Health Inc
ELV
Jul 17, 2026
Analyst
-
Signal & Target
BUY
$395.00
Start Price
$369.28
Best Price (1Y)
$404.72
Current Price
$398.22
Return
+7.8%
Twist Bioscience Corp
TWST
Jul 16, 2026
Analyst
Puneet Souda
Signal & Target
BUY
$110.00
Start Price
$92.61
Best Price (1Y)
$126.24
Current Price
$125.16
Return
+35.1%
Avalo Therapeutics Inc
AVTX
Jul 06, 2026
Analyst
-
Signal & Target
BUY
$38.00
Start Price
$19.80
Best Price (1Y)
$20.65
Current Price
$19.45
Return
-1.8%
Pyxis Oncology Inc
PYXS
Jul 02, 2026
Analyst
Jeffrey La Rosa
Signal & Target
BUY
$7.00
Start Price
$2.85
Best Price (1Y)
$4.00
Current Price
$3.01
Return
+5.6%
Lilly(Eli) & Co
LLY
Jun 25, 2026
Analyst
David Risinger
Signal & Target
BUY
$1,232.00
Start Price
$1,117.26
Best Price (1Y)
$1,249.45
Current Price
$1,209.85
Return
+8.3%
Bio-Techne Corp
TECH
Jun 25, 2026
Analyst
Market Perform
Signal & Target
BUY
$73.00
Start Price
$70.55
Best Price (1Y)
$72.40
Current Price
$72.17
Return
+2.3%
Rapport Therapeutics Inc.
RAPP
Jun 24, 2026
Analyst
-
Signal & Target
BUY
$52.00
Start Price
$38.88
Best Price (1Y)
$49.50
Current Price
$47.36
Return
+21.8%
Definium Therapeutics, Inc.
DFTX
Jun 22, 2026
Analyst
Marc Goodman
Signal & Target
BUY
$52.00
Start Price
$37.91
Best Price (1Y)
$49.70
Current Price
$43.90
Return
+15.8%
Regenxbio Inc
RGNX
Jun 22, 2026
Analyst
Mani Foroohar
Signal & Target
BUY
$18.00
Start Price
$8.88
Best Price (1Y)
$15.85
Current Price
$10.66
Return
+20.0%
Altimmune Inc
ALT
Jun 22, 2026
Analyst
Thomas Smith
Signal & Target
BUY
$10.00
Start Price
$3.01
Best Price (1Y)
$3.40
Current Price
$2.88
Return
-4.3%
uniQure N.V.
QURE
Jun 18, 2026
Analyst
Joseph Schwartz
Signal & Target
BUY
$70.00
Start Price
$48.16
Best Price (1Y)
$50.47
Current Price
$47.06
Return
-2.3%
Unitedhealth Group Inc
UNH
Jun 17, 2026
Analyst
Whit Mayo
Signal & Target
BUY
$462.00
Start Price
$407.65
Best Price (1Y)
$461.00
Current Price
$399.06
Return
-2.1%
Edgewise Therapeutics Inc
EWTX
Jun 16, 2026
Analyst
-
Signal & Target
BUY
$52.00
Start Price
$33.28
Best Price (1Y)
$48.40
Current Price
$43.18
Return
+29.7%
Procept BioRobotics Corp
PRCT
Jun 11, 2026
Analyst
-
Signal & Target
SELL
$29.00
Start Price
$29.09
Best Price (1Y)
$16.68
Current Price
$21.95
Return
+24.5%
Tango Therapeutics Inc
TNGX
Jun 08, 2026
Analyst
-
Signal & Target
BUY
$69.00
Start Price
$31.17
Best Price (1Y)
$33.53
Current Price
$25.65
Return
-17.7%
Stryker Corp.
SYK
Jun 05, 2026
Analyst
Mike Kratky
Signal & Target
BUY
$407.00
Start Price
$301.21
Best Price (1Y)
$352.46
Current Price
$341.09
Return
+13.2%
Nanobiotix - ADR
NBTX
Jun 04, 2026
Analyst
Jonathan Chang
Signal & Target
BUY
$46.00
Start Price
$35.20
Best Price (1Y)
$42.92
Current Price
$38.17
Return
+8.4%
Absci Corp
ABSI
Jun 04, 2026
Analyst
-
Signal & Target
BUY
$12.00
Start Price
$5.94
Best Price (1Y)
$12.00
Current Price
$9.46
Return
+59.3%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Jun 03, 2026
Analyst
Andrew Berens
Signal & Target
BUY
$165.00
Start Price
$91.35
Best Price (1Y)
$123.99
Current Price
$123.96
Return
+35.7%
Analyst
Michael Cherny
Signal & Target
SELL
$25.00
Start Price
$27.64
Best Price (1Y)
$24.24
Current Price
$28.77
Return
-4.1%
X4 Pharmaceuticals Inc
XFOR
Jun 02, 2026
Analyst
Thomas Smith
Signal & Target
BUY
$12.00
Start Price
$4.11
Best Price (1Y)
$4.82
Current Price
$4.29
Return
+4.4%
Celcuity Inc
CELC
Jun 02, 2026
Analyst
Andrew Berens
Signal & Target
BUY
$155.00
Start Price
$93.37
Best Price (1Y)
$117.21
Current Price
$86.60
Return
-7.3%
Fulcrum Therapeutics Inc
FULC
Jun 02, 2026
Analyst
-
Signal & Target
SELL
$4.00
Start Price
$6.42
Best Price (1Y)
$2.83
Current Price
$3.71
Return
+42.2%
Icon Plc
ICLR
May 28, 2026
Analyst
-
Signal & Target
BUY
$145.00
Start Price
$138.71
Best Price (1Y)
$186.64
Current Price
$167.48
Return
+20.7%
Boston Scientific Corp.
BSX
May 28, 2026
Analyst
Mike Kratky
Signal & Target
BUY
$74.00
Start Price
$50.46
Best Price (1Y)
$52.34
Current Price
$51.69
Return
+2.4%
Equillium Inc
EQ
May 28, 2026
Analyst
Thomas Smith
Signal & Target
BUY
$6.00
Start Price
$2.63
Best Price (1Y)
$3.54
Current Price
$2.01
Return
-23.6%
Lilly(Eli) & Co
LLY
May 26, 2026
Analyst
David Risinger
Signal & Target
BUY
$1,119.00
Start Price
$1,065.00
Best Price (1Y)
$1,249.45
Current Price
$1,209.85
Return
+13.6%
Twist Bioscience Corp
TWST
May 22, 2026
Analyst
Puneet Souda
Signal & Target
BUY
$80.00
Start Price
$58.84
Best Price (1Y)
$126.24
Current Price
$125.16
Return
+112.7%
Recent Upgrades / Downgrades
| Date | Stock | Action | From | To |
|---|---|---|---|---|
| Mar 18, 2026 |
BrightSpring Health Services Inc
BTSG
|
Hold | Outperform | Outperform |
| Mar 17, 2026 |
Cencora Inc.
COR
|
Hold | Outperform | Outperform |
| Mar 16, 2026 |
Structure Therapeutics Inc - ADR
GPCR
|
Hold | Outperform | Outperform |
| Mar 16, 2026 |
Spyre Therapeutics Inc.
SYRE
|
Hold | Outperform | Outperform |
| Mar 16, 2026 |
Eledon Pharmaceuticals Inc
ELDN
|
Hold | Outperform | Outperform |
| Mar 13, 2026 |
Century Therapeutics Inc
IPSC
|
Hold | Market Perform | Market Perform |
| Mar 12, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
Hold | Outperform | Outperform |
| Mar 12, 2026 |
Ardelyx Inc
ARDX
|
Hold | Outperform | Outperform |
| Mar 12, 2026 |
Tenaya Therapeutics Inc
TNYA
|
Hold | Outperform | Outperform |
| Mar 12, 2026 |
Rivian Automotive Inc - Ordinary Shares - Class A
RIVN
|
Hold | Outperform | Outperform |
| Mar 12, 2026 |
BridgeBio Pharma Inc
BBIO
|
Hold | Outperform | Outperform |
| Mar 10, 2026 |
Medtronic Plc
MDT
|
Hold | Outperform | Outperform |
| Mar 10, 2026 |
Zoetis Inc - Ordinary Shares - Class A
ZTS
|
Hold | Market Perform | Market Perform |
| Mar 10, 2026 |
ARS Pharmaceuticals Inc
SPRY
|
Hold | Outperform | Outperform |
| Mar 10, 2026 |
3D Systems Corp.
DDD
|
Hold | Outperform | Outperform |
| Mar 10, 2026 |
Cytokinetics Inc
CYTK
|
Hold | Outperform | Outperform |
| Mar 09, 2026 |
Henry Schein Inc.
HSIC
|
Hold | Market Perform | Market Perform |
| Mar 09, 2026 |
Cardinal Health, Inc.
CAH
|
Hold | Outperform | Outperform |
| Mar 09, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
Hold | Market Perform | Market Perform |
| Mar 06, 2026 |
CorMedix Inc
CRMD
|
Hold | Outperform | Outperform |
| Mar 05, 2026 |
Mckesson Corporation
MCK
|
Hold | Outperform | Outperform |
| Mar 05, 2026 |
AMGEN Inc.
AMGN
|
Hold | Market Perform | Market Perform |
| Mar 05, 2026 |
CVS Health Corp
CVS
|
Hold | Outperform | Outperform |
| Mar 03, 2026 |
SpyGlass Pharma, Inc. Common Stock
SGP
|
Downgrade | Market Perform | |
| Mar 03, 2026 |
Biohaven Ltd
BHVN
|
Hold | Outperform | Outperform |
| Mar 02, 2026 |
uniQure N.V.
QURE
|
Hold | Outperform | Outperform |
| Feb 26, 2026 |
Vir Biotechnology Inc
VIR
|
Hold | Outperform | Outperform |
| Feb 26, 2026 |
Acadia Healthcare Company Inc
ACHC
|
Hold | Market Perform | Market Perform |
| Feb 26, 2026 |
GoodRx Holdings Inc - Ordinary Shares - Class A
GDRX
|
Hold | Outperform | Outperform |
| Feb 26, 2026 |
Mirum Pharmaceuticals Inc
MIRM
|
Hold | Outperform | Outperform |
| Feb 26, 2026 |
Certara Inc
CERT
|
Hold | Outperform | Outperform |
| Feb 26, 2026 |
AdaptHealth Corp
AHCO
|
Hold | Outperform | Outperform |
| Feb 24, 2026 |
Gossamer Bio Inc
GOSS
|
Downgrade | Market Perform | |
| Feb 24, 2026 |
XOMA Royalty Corp.
XOMA
|
Hold | Outperform | Outperform |
| Feb 24, 2026 |
Fulcrum Therapeutics Inc
FULC
|
Hold | Outperform | Outperform |
| Feb 23, 2026 |
Enhabit Inc
EHAB
|
Hold | Market Perform | Market Perform |
| Feb 09, 2026 |
Hims & Hers Health Inc - Ordinary Shares - Class A
HIMS
|
Hold | Market Perform | Market Perform |
| Feb 03, 2026 |
Medtronic Plc
MDT
|
Hold | Outperform | Outperform |
| Jan 30, 2026 |
Moderna Inc
MRNA
|
Hold | Underperform | Underperform |
| Jan 21, 2026 |
RAPT Therapeutics Inc
RAPT
|
Downgrade | Market Perform | Market Perform |
| Jan 16, 2026 |
Penumbra Inc
PEN
|
Downgrade | Market Perform | |
| Jan 06, 2026 |
NewAmsterdam Pharma Company NV
NAMS
|
Hold | Outperform | Outperform |
| Jan 05, 2026 |
Icon Plc
ICLR
|
Hold | Outperform | Outperform |
| Dec 29, 2025 |
Ultragenyx Pharmaceutical Inc.
RARE
|
Hold | Outperform | Outperform |
| Dec 18, 2025 |
Lilly(Eli) & Co
LLY
|
Hold | Outperform | Outperform |
| Dec 18, 2025 |
Insmed Inc
INSM
|
Hold | Outperform | Outperform |
| Dec 17, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
Hold | Outperform | Outperform |
| Dec 16, 2025 |
Dexcom Inc
DXCM
|
Hold | Outperform | Outperform |
| Dec 15, 2025 |
Roivant Sciences Ltd
ROIV
|
Hold | Outperform | Outperform |
| Dec 15, 2025 |
Regenxbio Inc
RGNX
|
Hold | Outperform | Outperform |
Action
Hold
From
Outperform
To
Outperform
Cencora Inc.
COR
Mar 17
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Spyre Therapeutics Inc.
SYRE
Mar 16
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Market Perform
To
Market Perform
Action
Hold
From
Outperform
To
Outperform
Ardelyx Inc
ARDX
Mar 12
Action
Hold
From
Outperform
To
Outperform
Tenaya Therapeutics Inc
TNYA
Mar 12
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
BridgeBio Pharma Inc
BBIO
Mar 12
Action
Hold
From
Outperform
To
Outperform
Medtronic Plc
MDT
Mar 10
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Market Perform
To
Market Perform
ARS Pharmaceuticals Inc
SPRY
Mar 10
Action
Hold
From
Outperform
To
Outperform
3D Systems Corp.
DDD
Mar 10
Action
Hold
From
Outperform
To
Outperform
Cytokinetics Inc
CYTK
Mar 10
Action
Hold
From
Outperform
To
Outperform
Henry Schein Inc.
HSIC
Mar 09
Action
Hold
From
Market Perform
To
Market Perform
Cardinal Health, Inc.
CAH
Mar 09
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Market Perform
To
Market Perform
CorMedix Inc
CRMD
Mar 06
Action
Hold
From
Outperform
To
Outperform
Mckesson Corporation
MCK
Mar 05
Action
Hold
From
Outperform
To
Outperform
AMGEN Inc.
AMGN
Mar 05
Action
Hold
From
Market Perform
To
Market Perform
CVS Health Corp
CVS
Mar 05
Action
Hold
From
Outperform
To
Outperform
Action
Downgrade
From
-
To
Market Perform
Biohaven Ltd
BHVN
Mar 03
Action
Hold
From
Outperform
To
Outperform
uniQure N.V.
QURE
Mar 02
Action
Hold
From
Outperform
To
Outperform
Vir Biotechnology Inc
VIR
Feb 26
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Market Perform
To
Market Perform
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Certara Inc
CERT
Feb 26
Action
Hold
From
Outperform
To
Outperform
AdaptHealth Corp
AHCO
Feb 26
Action
Hold
From
Outperform
To
Outperform
Gossamer Bio Inc
GOSS
Feb 24
Action
Downgrade
From
-
To
Market Perform
XOMA Royalty Corp.
XOMA
Feb 24
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Enhabit Inc
EHAB
Feb 23
Action
Hold
From
Market Perform
To
Market Perform
Action
Hold
From
Market Perform
To
Market Perform
Medtronic Plc
MDT
Feb 03
Action
Hold
From
Outperform
To
Outperform
Moderna Inc
MRNA
Jan 30
Action
Hold
From
Underperform
To
Underperform
RAPT Therapeutics Inc
RAPT
Jan 21
Action
Downgrade
From
Market Perform
To
Market Perform
Penumbra Inc
PEN
Jan 16
Action
Downgrade
From
-
To
Market Perform
Action
Hold
From
Outperform
To
Outperform
Icon Plc
ICLR
Jan 05
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Lilly(Eli) & Co
LLY
Dec 18
Action
Hold
From
Outperform
To
Outperform
Insmed Inc
INSM
Dec 18
Action
Hold
From
Outperform
To
Outperform
Action
Hold
From
Outperform
To
Outperform
Dexcom Inc
DXCM
Dec 16
Action
Hold
From
Outperform
To
Outperform
Roivant Sciences Ltd
ROIV
Dec 15
Action
Hold
From
Outperform
To
Outperform
Regenxbio Inc
RGNX
Dec 15
Action
Hold
From
Outperform
To
Outperform